Microsteps Study-Short, Animated Storytelling Video
Launched by STANFORD UNIVERSITY · May 12, 2025
Trial Information
Current as of July 24, 2025
Completed
Keywords
ClinConnect Summary
The Microsteps Study is looking at how short, animated storytelling videos and written messages can help people adopt healthier behaviors. The researchers want to see if watching these videos and reading the messages can encourage participants to make positive changes in their daily habits right after they see them and also two weeks later. They will also explore how these messages affect participants' feelings of hope and happiness, as well as whether they continue to engage with the health messages after the trial is over. This study will be conducted entirely online.
To take part in the study, participants need to be between the ages of 18 and 75, live in the U.S. or the U.K., and be registered on the Prolific Academic platform. Importantly, they must be using a specific type of medication called GLP-1 receptor agonists (GLP-1RA). There are no other specific requirements to join. Participants can expect to watch some videos, read messages about healthy behaviors, and share their thoughts on how these materials impacted their attitudes and actions regarding their health.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Registered with the Prolific Academic platform
- • Using a GLP-1RA medication or having used a GLP-1RA medication in the past.
- Exclusion Criteria:
- • None
About Stanford University
Stanford University is a prestigious academic institution renowned for its cutting-edge research and innovation in healthcare and medicine. As a clinical trial sponsor, Stanford leverages its extensive resources, including a collaborative network of world-class researchers and state-of-the-art facilities, to advance medical knowledge and improve patient care. The university is committed to conducting rigorous, ethical research that adheres to the highest standards of scientific integrity, fostering an environment where groundbreaking discoveries can translate into effective clinical applications. Through its clinical trials, Stanford aims to address critical health challenges and contribute to the development of novel therapies and treatment strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Stanford, California, United States
Patients applied
Trial Officials
Maya Adam, MD
Principal Investigator
Stanford University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported